Terumo Corporation Overview
Pro stress-test →Terumo is a global leader in medical technology with over 100 years of heritage in healthcare innovation. The company produces prefilled syringes, insulin patch pumps, neurovascular and cardiac vascular interventional devices, and blood processing systems, with cardiac and vascular business contributing over 60% of total revenue. North America represents 38% of Terumo's revenue, establishing it as a truly global player.
Strategic Profile
Pro stress-test →Strong product innovation, market share gains, and demographic trends position the company for sustained expansion, while operational improvements and strategic R&D investments support long-term margin growth. Growing demand in major markets and effective pricing increases in cardiovascular segments, combined with expansion in China and high-margin consumables, are boosting profitability and cash flow.
Competitive Landscape
Pro stress-test →Primary competitors include Boston Scientific, Medtronic, and Merit Medical Systems, alongside regional players like Japan Lifeline and Asahi Intecc. Terumo competes through product innovation, manufacturing excellence, and market share gains in high-margin therapeutic segments.
Industry Context
Terumo Corporation operates in Medical Devices & Healthcare Technology.
Key facts
Founded: 1921 · Headquarters: Tokyo, Japan · Employees: 30,000+ · Revenue: 1.04 trillion JPY (2024)